Data / Form D filings / Vesicor Therapeutics, Inc.
Vesicor Therapeutics, Inc.: Form D filings
Vesicor Therapeutics, Inc., a biotechnology company in San Gabriel, CA, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on May 14, 2025, reports $515,000 sold of a $3 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 207 S. SANTA ANITA STREET, SUITE P-15, San Gabriel, CA, 91776
- Phone
- (626) 400-6603
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1993074
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2025 | New notice | $3,000,000 | $515,000 | $2,485,000 | 12 | Jul 3, 2024 | sec.gov |
| Sep 14, 2023 | New notice | $3,000,000 | $200,000 | $2,800,000 | 2 | Sep 7, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Bowen | Executive Officer | |
| Warren Jr. Hosseinion | Executive Officer | |
| Oded Levy | Director | |
| Luo Feng | Executive Officer, Director | |
| Warren Hosseinion | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 12, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vesicor Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.